| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 07/29/2004 | US20040146896 Methods and compositions for diagnosing and treating companion animal cancer |
| 07/29/2004 | US20040146893 Nucleotide sequences coding heterologous polypeptide for use in diagnosis and treatment of nervous system, cell proliferative, inflammatory and autoimmune diseases; wound healing agents |
| 07/29/2004 | US20040146892 Expression vector coding organelle transport protein for use in identifying modulators of adenine nucleotide translocator and cyclophilin d interaction |
| 07/29/2004 | US20040146891 Comprises growth factor for diagnosis and treatment of immunological and cell proliferative disorders |
| 07/29/2004 | US20040146888 Cystine-knot polypeptides: cloaked-2 molecules and uses thereof |
| 07/29/2004 | US20040146887 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 07/29/2004 | US20040146884 Antifreeze proteins isolated from forage grasses and methods for their use |
| 07/29/2004 | US20040146882 Human acid sensing ion channel 2b (hASIC2b), process for producing the same, and its use |
| 07/29/2004 | US20040146879 Novel human genes and gene expression products |
| 07/29/2004 | US20040146877 Diagnosis and treatment of cancer:I |
| 07/29/2004 | US20040146873 Advanced sleep phase syndrome gen in humans |
| 07/29/2004 | US20040146872 Comprises nucleotide sequences coding delta-2-enoyl-coA isomerase for use in identifying modulators for treatment and diagnosis of inflammatory, cardiovascular, skin, body weight and cancer disorders |
| 07/29/2004 | US20040146861 Diagnosing and treating cancer cells using mutant viruses |
| 07/29/2004 | US20040146860 Nucleic acid and amino acid sequences of infectious salmon anaemia virus and their use as vaccines |
| 07/29/2004 | US20040146859 Nucleotide sequences coding hemorrhagic viral protein for use in detection and treatment of viral diseases; viricides; genetic vaccines |
| 07/29/2004 | US20040146851 Identifying compounds which modulate phosphatidylserine exposure on the surface of megakaryocytes for use in treating thrombosis, bleeding and apoptosis disorders |
| 07/29/2004 | US20040146549 Amino acid sequences capable of facilitating penetration across a biological barrier |
| 07/29/2004 | US20040146531 Virus-like particles devoid of HPV 16 type-specific antibody epitopes as carriers of peptides for introduction into cells |
| 07/29/2004 | US20040146529 HBV/HCV virus-like particle |
| 07/29/2004 | US20040146528 MVA expressing modified HIV envelope, gag, and pol genes |
| 07/29/2004 | US20040146527 Pertussis toxin gene: cloning and expression of protective antigen |
| 07/29/2004 | US20040146526 Inhibition of NF-kappaB activation |
| 07/29/2004 | US20040146525 Shellfish protein |
| 07/29/2004 | US20040146524 Immunogen for a vaccine or inoculum |
| 07/29/2004 | US20040146522 For therapy of individual exposed to or infected with HIV-1 |
| 07/29/2004 | US20040146520 Materials and methods relating to immune suppression |
| 07/29/2004 | US20040146519 For use in vaccines, prophylaxis and therapy of cancer |
| 07/29/2004 | US20040146510 Genetically engineered polypeptides as wound healing agents; treatment of nervous system, vision, kidney, and liver disorders; stimulating embryogenesis and angiogenesis; antitumor agents; drug screening, diagnosis |
| 07/29/2004 | US20040146508 Use of cd25 binding molecules in steroid-resistant patients |
| 07/29/2004 | US20040146506 Antibodies specific for a cell surface molecule mediating cell adhesion and signal transmission, cells secreting such antibodies, and methods of making and using such antibodies |
| 07/29/2004 | US20040146504 Anti-IgE vaccines |
| 07/29/2004 | US20040146501 Polynucleotides, recombinant vectors and host cells for gene expression; antibody fragments |
| 07/29/2004 | US20040146489 Replication competent adenovirus vectors comprising co-transcribed first and second genes under transcriptional control of a heterologous, target cell-specific transcriptional regulatory element (TRE) |
| 07/29/2004 | US20040146459 Renal nuclear matrix proteins, polynucleotide sequences encoding them, and their use |
| 07/29/2004 | US20040144397 Modifying nicotine and nitrosamine levels in tobacco |
| 07/29/2004 | DE10301255A1 Organische Verbindungen mit biologischer Wirkung als Thrombinhemmer und ihre Verwendung Organic compounds having biological activity as thrombin inhibitors and their use |
| 07/29/2004 | DE10232322A1 Viral kodierte CxC determinieren den Gewebetropismus von HCMV Virally encoded CxC determine the tissue tropism of HCMV |
| 07/29/2004 | DE10045016B4 Retrovirale Vektoren mit Fremdsequenzinsertion zwischen retroviraler Primerbindungsstelle und retroviralem Spleißdonor Retroviral vectors with Fremdsequenzinsertion between retroviral primer binding site and retroviral splice donor |
| 07/29/2004 | CA2513466A1 Organic compounds with biological action as thrombin inhibitors and use thereof |
| 07/29/2004 | CA2513300A1 Obesity-related genes |
| 07/29/2004 | CA2513218A1 Peptides and uses thereof for preventing and treating alzheimer's disease(ad) |
| 07/29/2004 | CA2513107A1 Protein microarray system |
| 07/29/2004 | CA2512974A1 Soluble fc.gamma.r fusion proteins and methods of use thereof |
| 07/29/2004 | CA2512812A1 Compositions, methods and kits for enhancing the immunogenicity of a bacterial vaccine vector |
| 07/29/2004 | CA2512681A1 Stabilized aqueous compositions comprising tissue factor pathway inhibitor (tfpi) or tissue factor pathway inhibitor variant |
| 07/29/2004 | CA2512399A1 F11 receptor(f11r) antagonists as therapeutic agents |
| 07/29/2004 | CA2512392A1 Human calcium transporter 1 gene, screening method of calcium absorption regulating factor, and calcium absorption regulating factor |
| 07/29/2004 | CA2512151A1 Method for producing ketocarotenoids by cultivating genetically modified organisms |
| 07/29/2004 | CA2512085A1 Protein complex, process for producing the same and use thereof |
| 07/29/2004 | CA2511858A1 Metastin derivative and use thereof |
| 07/29/2004 | CA2511853A1 Novel fibulin-like polypeptides |
| 07/29/2004 | CA2511800A1 Low efficacy gonadotropin agonists and antagonists |
| 07/29/2004 | CA2511659A1 Methods for reducing mortality associated with acute myocardial infarction |
| 07/29/2004 | CA2511564A1 Novel preadipocyte factor-1-like polypeptides |
| 07/29/2004 | CA2511556A1 Novel fibrillin-like polypeptides |
| 07/29/2004 | CA2510401A1 Defensin proteins |
| 07/29/2004 | CA2509422A1 Method for preparing recombinant heterocarpine |
| 07/29/2004 | CA2506987A1 Proteorhodopsin mutants with improved optical characteristics |
| 07/29/2004 | CA2482850A1 A method for the evaluation of hair-growth promoting activity |
| 07/28/2004 | EP1441034A1 Methods of evaluating phosphatase inhibitors |
| 07/28/2004 | EP1441032A1 Methods of assaying receptor activity and constructs useful in such methods |
| 07/28/2004 | EP1441031A1 Enzyme gene participating in the synthesis of polyester and process for producing polyester using the same |
| 07/28/2004 | EP1441030A1 Method of purifying recombinant fused protein and method of producing protein using the same |
| 07/28/2004 | EP1440982A2 Ifn-thy fusion protein, dna coding therefore, its preparation and application |
| 07/28/2004 | EP1440981A2 Full-length human cdna |
| 07/28/2004 | EP1440980A2 Peptide analogs of human myelin basic protein |
| 07/28/2004 | EP1440979A1 Process for the preparation of hypoallergenic mosaic proteins |
| 07/28/2004 | EP1440166A2 Methods and compositions for the diagnosis and treatment of hematological disorders using 2777 |
| 07/28/2004 | EP1440165A2 Methods and compositions for the treatment and diagnosis of cellular proliferation disorders using 25943 |
| 07/28/2004 | EP1440157A1 Methods and means for producing proteins with predetermined post-translational modifications |
| 07/28/2004 | EP1440156A2 Antigens and vectors for vaccination |
| 07/28/2004 | EP1440151A2 Seed specific 7s alpha promoter for expressing genes in plants |
| 07/28/2004 | EP1440149A2 Infectious and attenuated bovine viral diarrhea virus clones; methods for their production and use |
| 07/28/2004 | EP1440092A2 Photoactivatable composition and the use of same |
| 07/28/2004 | EP1440091A1 Nogo receptor homologues and their use |
| 07/28/2004 | EP1440090A2 A synthetic chimeric fusion protein with immuno-therapeutic uses |
| 07/28/2004 | EP1440089A2 Human angiomotin-like protein 1 |
| 07/28/2004 | EP1440088A2 Precursor silk feedstock for forming filaments |
| 07/28/2004 | EP1440087A2 Mycobacterial genes down-regulated during latency |
| 07/28/2004 | EP1440086A1 Infectious salmon anaemia virus vaccine |
| 07/28/2004 | EP1440085A2 Transient immortalization of cells by oncogenic proteins or telomerase |
| 07/28/2004 | EP1440084A2 Sperm factor sequences |
| 07/28/2004 | EP1440083A2 Molecules |
| 07/28/2004 | EP1439854A2 Conformationally constrained parathyroid hormone (pth) analogs |
| 07/28/2004 | EP1439852A1 Peptides and related compounds having thrombopoietic activity |
| 07/28/2004 | EP1439850A1 Soluble proteins that inhibit cytokine signal transduction pathways |
| 07/28/2004 | EP1439849A2 Use of calmodulin kinase ii inhibitors to treat myocardial dysfunction in structural heart disease |
| 07/28/2004 | EP1439846A2 Storage-stable human fibrinogen solutions |
| 07/28/2004 | EP1401473A4 Transporters comprising spaced arginine moieties |
| 07/28/2004 | EP1284994B1 Use of a high-molecular-weight extracellular haemoglobin as blood substitute |
| 07/28/2004 | EP1265912A4 Mass1 gene, a target for anticonvulsant drug development |
| 07/28/2004 | EP1238095A4 Compositions and methods for caspase-induced apoptosis |
| 07/28/2004 | EP1226244B1 Polypeptides with non-natural primary signalling motifs |
| 07/28/2004 | EP1090668B1 Chelate-forming filter, process for producing the same |
| 07/28/2004 | EP1078085B1 Use of a polypeptide derived from a pa1b legume albumen as insecticide |
| 07/28/2004 | EP1047781B1 Il-18 receptors |
| 07/28/2004 | EP1028739B1 Use of protein h as cytostatic agent |
| 07/28/2004 | EP1012341A4 An alpha-2 macroglobulin diagnostic test |
| 07/28/2004 | EP0981651B1 Detection of retroviral subtypes based upon envelope specific sequences |
| 07/28/2004 | EP0941311B1 Type i recombinant clostridium histolyticum collagenase and its use for isolating cells and cell aggregates |